1. Home
  2. SINT vs INAB Comparison

SINT vs INAB Comparison

Compare SINT & INAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SINT
  • INAB
  • Stock Information
  • Founded
  • SINT 1996
  • INAB 2016
  • Country
  • SINT United States
  • INAB United States
  • Employees
  • SINT N/A
  • INAB N/A
  • Industry
  • SINT Medical/Dental Instruments
  • INAB Biotechnology: Pharmaceutical Preparations
  • Sector
  • SINT Health Care
  • INAB Health Care
  • Exchange
  • SINT Nasdaq
  • INAB Nasdaq
  • Market Cap
  • SINT 11.6M
  • INAB 10.6M
  • IPO Year
  • SINT 2014
  • INAB 2021
  • Fundamental
  • Price
  • SINT $3.30
  • INAB $1.56
  • Analyst Decision
  • SINT Strong Buy
  • INAB Strong Buy
  • Analyst Count
  • SINT 1
  • INAB 2
  • Target Price
  • SINT $25.00
  • INAB $108.00
  • AVG Volume (30 Days)
  • SINT 411.0K
  • INAB 68.9K
  • Earning Date
  • SINT 11-13-2025
  • INAB 11-06-2025
  • Dividend Yield
  • SINT N/A
  • INAB N/A
  • EPS Growth
  • SINT N/A
  • INAB N/A
  • EPS
  • SINT N/A
  • INAB N/A
  • Revenue
  • SINT $1,861,000.00
  • INAB N/A
  • Revenue This Year
  • SINT N/A
  • INAB N/A
  • Revenue Next Year
  • SINT $80.00
  • INAB N/A
  • P/E Ratio
  • SINT N/A
  • INAB N/A
  • Revenue Growth
  • SINT N/A
  • INAB N/A
  • 52 Week Low
  • SINT $1.71
  • INAB $1.53
  • 52 Week High
  • SINT $8.60
  • INAB $12.53
  • Technical
  • Relative Strength Index (RSI)
  • SINT 42.72
  • INAB 21.67
  • Support Level
  • SINT $3.03
  • INAB $1.55
  • Resistance Level
  • SINT $3.53
  • INAB $2.14
  • Average True Range (ATR)
  • SINT 0.30
  • INAB 0.14
  • MACD
  • SINT -0.01
  • INAB -0.05
  • Stochastic Oscillator
  • SINT 34.20
  • INAB 4.75

About SINT SiNtx Technologies Inc.

SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.

Share on Social Networks: